Physician

Guri Bronner, MD

According to 2025 Medicare claims, Guri Bronner, MD (NPI: 1962586073) practices ophthalmology in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is BERKS EYE PHYSICIANS & SURGEONS LTD (NPI: 1548221302; TIN: 231720360) and primary practice location at 19610-1100.

Bronner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,214 traditional Medicare patients, billed 26,975 HCPCS/CPT codes, and received $3,661,188 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 349 prescription claims across 135 beneficiaries totaling $18,493 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 25 records totaling $540. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,437,525 to $3,661,188. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.2M2015 Medicare payment: $2,437,525 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,854,624 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,065,155 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,559,101 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,850,198 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,802,071 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,208,239 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,898,635 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,913,230 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,661,188 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,14214,404$2,437,525
20161,25014,785$2,854,624
20171,28914,653$3,065,155
20181,37816,035$3,559,101
20191,43317,054$3,850,198
20201,34515,439$3,802,071
20211,45616,796$4,208,239
20221,42915,610$3,898,635
20231,16717,032$3,913,230
20241,21426,975$3,661,188

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$40K2015 Drug cost: $14,140 (USD; Tot_Drug_Cst)2016 Drug cost: $24,352 (USD; Tot_Drug_Cst)2017 Drug cost: $30,992 (USD; Tot_Drug_Cst)2018 Drug cost: $37,850 (USD; Tot_Drug_Cst)2019 Drug cost: $35,379 (USD; Tot_Drug_Cst)2020 Drug cost: $32,254 (USD; Tot_Drug_Cst)2021 Drug cost: $39,233 (USD; Tot_Drug_Cst)2022 Drug cost: $39,949 (USD; Tot_Drug_Cst)2023 Drug cost: $24,255 (USD; Tot_Drug_Cst)2024 Drug cost: $18,493 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201589169$14,140
201693245$24,352
2017115279$30,992
2018130337$37,850
2019159377$35,379
2020121352$32,254
2021121289$39,233
2022121326$39,949
2023123305$24,255
2024135349$18,493

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3483,406$654
92014Established patient complete exam of visual system1,1453,293$90
67028Injection of drug into eye4032,187$87
92134Imaging of retina1,1763,611$30
92201Extended exam of the back part of the eye with retinal drawing132207$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium11427$3,485
Prednisolone AcetatePrednisolone Acetate732,799$2,825
Atropine SulfateAtropine Sulfate451,587$1,331
Ketorolac TromethamineKetorolac Tromethamine451,484$763
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha581,072$655

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$540Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Guri Bronner, MD?

Tedicare shows public-source Medicare data for Guri Bronner, MD (NPI 1962586073), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Guri Bronner, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Guri Bronner, MD?

Guri Bronner, MD is linked to BERKS EYE PHYSICIANS & SURGEONS LTD (billing NPI 1548221302) in the available physician profile data.

Does Guri Bronner, MD have Open Payments data?

Guri Bronner, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.